Insights

Gathering insights about Acumen…

Similar companies to Acumen

Acumen Tech Stack

Acumen uses 8 technology products and services including HubSpot Analytics, jsDelivr, Google Cloud, and more. Explore Acumen's tech stack below.

HubSpot Analytics
Analytics
jsDelivr
Content Delivery Network
Google Cloud
Infrastructure As A Service
Envoy
Load Balancers
PHP
Programming Languages
reCAPTCHA
Security
MediaElement.js
Video Players
Nginx
Web Servers

Media & News

JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer's Disease, Enabled by J-Brain Cargo® Technology Platform
HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TSE 4552; JCR), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced that Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) exercised its exclusive option to develop, manufacture, and commercialize, on a global basis, up to two candidates for development in the treatment of Alzheimer's disease (AD), enabled by JCR's proprietary blood-brain barrier (BBB)-penetrating technology platform, J-Brain Cargo®
Jun 17, 2026 | www.businesswire.com
Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer's Disease
ACU301 and ACU401 were nominated in the EBD program as part of the exercise of Acumen's option under its license agreement with JCR Pharmaceuticals EBD technology represents the only anti-amyloid oligomer program combining a validated blood-brain barrier-penetrating technology with a therapeutic antibody tested in the clinic Acumen's EBD candidates are designed to achieve higher brain penetration with potential for improved safety compared to native antibodies and delivered in a stable, low volume subcutaneous administration format Investigational New Drug (IND)-enabling activities are ongoing to support IND submission in mid-2027 NEWTON, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen or the Company), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer's disease (AD), today announced the nomination of two development candidates in its Enhanced Brain Delivery (EBD) program as treatments for AD.
Jun 16, 2026 | www.globenewswire.com
Acumen's Late-2026 Sabirnetug Readout Is A Viable Bet
Acumen Pharmaceuticals is a clinical-stage Alzheimer's biotech built around sabirnetug. I believe 2026 will be mostly about its upcoming Phase 2 readout. The main appeal still lies with sabirnetug, which could offer meaningful upside if Phase 2 data supports a viable path into Phase 3. As such, ALTITUDE-AD is the main swing factor, especially if iADRS slowing lands near management's target.
May 20, 2026 | seekingalpha.com
Acumen Pharmaceuticals, Inc. (ABOS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Acumen Pharmaceuticals, Inc. (ABOS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
May 14, 2026 | seekingalpha.com
Acumen Pharmaceuticals, Inc. (ABOS) Q1 2026 Earnings Call Transcript
Acumen Pharmaceuticals, Inc. (ABOS) Q1 2026 Earnings Call Transcript
May 12, 2026 | seekingalpha.com
Acumen Pharmaceuticals Q1 Earnings Call Highlights
Acumen Pharmaceuticals NASDAQ: ABOS said its Phase 2 ALTITUDE-AD trial of sabirnetug remains on track, with top-line results expected late in 2026, as the company continues to advance its broader Alzheimer's disease pipeline.
May 12, 2026 | www.marketbeat.com
Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights
NEWTON, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer's disease (AD), today reported financial results for the first quarter of 2026 and provided a business update.
May 12, 2026 | www.globenewswire.com

Acumen's Email Address Formats

Acumen uses at least 1 format(s):

Acumen Email Formats	Example	Percentage
First.Last@acumenimpact.com	John.Doe@acumenimpact.com	78%
FLast@acumenimpact.com	JDoe@acumenimpact.com	11%
First.MiddleLast@acumenimpact.com	John.MichaelDoe@acumenimpact.com	11%

Frequently Asked Questions

Where is Acumen's headquarters located?

Acumen's main headquarters is located at 8101 College Boulevard Suite 100 Overland Park, Kansas 66210 United States. The company has employees across 1 continents, including North America.

What is Acumen's stock symbol?

Acumen is a publicly traded company; the company's stock symbol is ABOS.

What is Acumen's official website and social media links?

Acumen's official website is acumenimpact.com and has social profiles on LinkedIn.

What is Acumen's NAICS code?

Acumen's NAICS code is 6114 - Business Schools and Computer and Management Training.

How many employees does Acumen have currently?

As of June 2026, Acumen has approximately 22 employees across 1 continents, including North America. Key team members include Ceo: D. C.Fractional Growth Partner: E. S.Director Of Client Experience: A. N.. Explore Acumen's employee directory with LeadIQ.

What industry does Acumen belong to?

Acumen operates in the Professional Training and Coaching industry.

What technology does Acumen use?

Acumen's tech stack includes HubSpot AnalyticsjsDelivrGoogle CloudEnvoyPHPreCAPTCHAMediaElement.jsNginx.

What is Acumen's email format?

Acumen's email format typically follows the pattern of First.Last@acumenimpact.com. Find more Acumen email formats with LeadIQ.

When was Acumen founded?

Acumen was founded in 2015.

Acumen

Q: What is Acumen's official website and social media links?

Acumen's official website is acumenimpact.com. Acumen has social profiles on LinkedIn.

Q: How many employees does Acumen have currently?

Acumen has approximately 22 employees.

Q: What technology does Acumen use?

Acumen's tech stack includes Astra, Nginx, html5media, Facebook, Cloudflare Bot Management.

Q: What is Acumen's NAICS code?

Acumen's NAICS code is 6114 (Business Schools and Computer and Management Training).

Professional Training and CoachingKansas, United States11-50 Employees

Headquartered in Overland Park, Kansas, Acumen serves executives and entrepreneurs through a collaborative environment that emphasizes personal and professional development. The company presents its services as an ongoing development ecosystem for top-level management, supported by a framework of regular gatherings and immersive experiences aimed at sharpening strategic orientation and leadership capabilities.

Company Overview

Headquarters: 8101 College Boulevard Suite 100 Overland Park, Kansas 66210 United States
Website: acumenimpact.com
Stock Symbol: ABOS
NAICS Code: 6114 - Business Schools and Computer and Management Training
Founded: 2015
Employees: 11-50

Media & News

Funding & Financials

$1M$10M
Acumen's revenue is estimated to be in the range of $1M$10M

Funding & Financials

$1M$10M
Acumen's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Acumen

Social Venture Partners International

Skoll Foundation

Omidyar Network

Benetech

Ashoka

Echoing Green

Root Capital

Acumen Tech Stack

Media & News

JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer's Disease, Enabled by J-Brain Cargo® Technology Platform

Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer's Disease

Acumen's Late-2026 Sabirnetug Readout Is A Viable Bet

Acumen Pharmaceuticals, Inc. (ABOS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Acumen Pharmaceuticals, Inc. (ABOS) Q1 2026 Earnings Call Transcript

Acumen Pharmaceuticals Q1 Earnings Call Highlights

Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights

Acumen's Email Address Formats

Frequently Asked Questions

Where is Acumen's headquarters located?

What is Acumen's stock symbol?

What is Acumen's official website and social media links?

What is Acumen's NAICS code?

How many employees does Acumen have currently?

What industry does Acumen belong to?

What technology does Acumen use?

What is Acumen's email format?

When was Acumen founded?

Acumen

Company Overview

Media & News

JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer's Disease, Enabled by J-Brain Cargo® Technology Platform

Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer's Disease

Acumen's Late-2026 Sabirnetug Readout Is A Viable Bet

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?